Exercise to preserve beta cell function in recent-onset type 1 diabetes mellitus (EXTOD) - a study protocol for a pilot randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Lascar, Nadia ^a   Kennedy, Amy ^a   Jackson, Nikki ^b   Daley, Amanda ^a   Dowswell, George ^a   Thompson, Dylan ^c   Stokes, Keith ^c   Greenfield, Sheila ^a   Holder, Roger ^a   Andrews, Rob ^b   Narendran, Parth ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Barriers; Beta cell function; C peptide; Exercise; Lifestyle; Physical activity; Type 1 diabetes

Indexed keywords

C PEPTIDE; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EXERCISE; EXERCISE INTENSITY; FITNESS; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; PILOT STUDY; PRESERVATION; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL;

BIOLOGICAL MARKERS; C-PEPTIDE; CLINICAL PROTOCOLS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; ENGLAND; EXERCISE THERAPY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MOTIVATION; PATIENT COMPLIANCE; PATIENT SELECTION; PHYSICAL FITNESS; PILOT PROJECTS; POSTPRANDIAL PERIOD; RESEARCH DESIGN; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879035361     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-180     Document Type: Article

References (39)

1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001, 358(9277):221-229. 10.1016/S0140-6736(01)05415-0, 11476858.
2. Gardner SG, Bingley PJ, Sawtell PA, Weeks S, Gale EA. Rising incidence of insulin dependent diabetes in children aged under five years in the Oxford region: time trend analysis. The Bart's-Oxford study group. BMJ 1997, 315(7110):713-717. 10.1136/bmj.315.7110.713, 2127500, 9314756.
3. Making every young person with diabetes matter. Report of the children and young people with diabetes working group 2007, London: Department of Health Diabetes Policy Team.
4. Sherry NA, Tsai EB, Herold KC. Natural history of beta cell function in type 1 diabetes. Diabetes 2005, 54(Suppl 2):S32-S39.
5. Scholin A, et al. Islet antibodies and remaining beta cell function eight years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide diabetes incidence study in Sweden. J Intern Med 2004, 255(3):384-391. 10.1046/j.1365-2796.2003.01273.x, 14871463.
6. Greenbaum CJ, et al. Preservation of beta cell function in autoantibody positive youth with diabetes. Diabetes Care 2009, 32(10):1839-1844. 10.2337/dc08-2326, 2752937, 19587365.
7. Keenan HA, Sun JK, Levine J, et al. Residual insulin production and pancreatic beta cell turnover after 50 years of diabetes: Joslin medalist study. Diabetes 2010, 59:2846-2853. 10.2337/db10-0676, 2963543, 20699420.
8. Montanya E, Fernandez-Castaner M, Soler J. Improved metabolic control preserved beta cell function two years after diagnosis of insulin dependent diabetes mellitus. Diabetes Metab 1997, 23(4):314-319.
9. The DCCT Research Group Effect of intensive therapy on residual ß cell function in patients with type I diabetes in the diabetes control and complications trial. Ann Intern Med 1998, 128:517-523. The DCCT Research Group.
10. Sjoberg S, et al. Residual insulin production, glycemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987, 30(4):208-213. 10.1007/BF00270417, 3297896.
11. Steffes MW, et al. Beta cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003, 26(3):832-836. 10.2337/diacare.26.3.832, 12610045.
12. Fleming A. What will it take to get therapies approved for type 1 diabetes?. Ann N Y Acad Sci 2008, 1150:25-31. 10.1196/annals.1447.043, 19120263.
13. Kruszynska YT, et al. Basal and 24-hour C peptide and insulin secretion rate in normal man. Diabetologia 1987, 30(1):16-21. 10.1007/BF01788901, 3552817.
14. Ludvigsson J, et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 2008, 359(18):1909-1920. 10.1056/NEJMoa0804328, 18843118.
15. Little RR, Rohlfing CL, Tennill AL, et al. Standardization of C peptide measurements. Clin Chem 2008, 54:1023-1026. 10.1373/clinchem.2007.101287, 18420730.
16. Wang L, Lovejoy N, Faustman DL. Persistence of prolonged C peptide production in type 1 diabetes with an ultrasensitive C peptide assay. Diabetes Care 2012, 35:465-470. 10.2337/dc11-1236, 3322715, 22355018.
17. Greenbaum CJ. Dead or alive?. Diabetes Care 2012, 35(3):459-460. 10.2337/dc11-2441, 3322728, 22355015.
18. Thrower SL, James L, Hall W, Green KM, Arif S, Allen JS, Van-Krinks C, Lozanoska-Ochser B, Marquesini L, Brown S, Wong FS, Dayan CM, Peakman M. Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man phase I safety study. Clin Exp Immunol 2009, 155(2):156-165. 10.1111/j.1365-2249.2008.03814.x, 2675245, 19040615.
19. Herold KC, Gitelman SE, Willi SM, Gottlieb PA, Waldron-Lynch F, Devine L, Sherr J, Rosenthal SM, Adi S, Jalaludin MY, Michels AW, Dziura J, Bluestone JA. Teplizumab treatment may improve C peptide responses in participants with type 1 diabetes after the new-onset period: a randomized controlled trial. Diabetologia 2013, 56(2):391-400. 10.1007/s00125-012-2753-4, 23086558.
20. Chatenoud L. Immune therapy for type 1 diabetes mellitus - what is unique about anti-CD3 antibodies?. Nat Rev Endocrinol 2010, 6(3):149-157. 10.1038/nrendo.2009.275, 20173776.
21. Choi SB, Jang JS, Park S. Estrogen and exercise may enhance beta cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology 2005, 146(11):4786-4794. 10.1210/en.2004-1653, 16037383.
22. Choi SB, Jang JS, Hong SM, Jun DW, Park S. Exercise and dexamethasone oppositely modulate beta cell function and survival via independent pathways in 90% pancreatectomized rats. J Endocrinology 2006, 190(2):471-482.
23. Coskun O, Ocakci A, Bayraktaroglu T, Kanter M. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta cell damage in rat pancreas. Tohoku J Exp Med 2004, 203(3):145-154. 10.1620/tjem.203.145, 15240923.
24. Park S, Hong SM, Lee JE, Sung SR. Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta cell function and mass through IRS2 in diabetic rats. J Appl Physiol 2007, 103(5):1764-1771. 10.1152/japplphysiol.00434.2007, 17761790.
25. Ertek S, Cicero A. Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions. Arch Med Sci 2012, 8(5):794-804. 3506236, 23185187.
26. Dela F, Von Linstow ME, Mikines KJ, Galbo H. Physical training may enhance beta cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 2004, 287(5):E1024-E1031. 10.1152/ajpendo.00056.2004, 15251867.
27. Bloem CJ, Chang AM. Short-term exercise improves beta cell function and insulin resistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab 2008, 93:387-392. 10.1210/jc.2007-1734, 2243226, 18000089.
28. Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H, Diabetes Prevention Program Research Group Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: effects of lifestyle intervention and metformin. Diabetes 2005, 8:2404-2414. Diabetes Prevention Program Research Group.
29. Slentz CA, Tanner CJ, Bateman LA, Durheim MT, Huffman KM, Houmard JA, Kraus WE. Effects of exercise training intensity on pancreatic beta cell function. Diabetes Care 2009, 32(10):1807-1811. 10.2337/dc09-0032, 2752909, 19592624.
30. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet 2008, 371(9626):1783-1789. 10.1016/S0140-6736(08)60766-7, 18502303.
31. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346(6):393-403. 1370926, 11832527, Diabetes Prevention Program Research Group.
32. Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, Jackson N, Fitzsimons K, Bright J, Coulman K, England CY, Gorton J, McLenaghan A, Paxton E, Polet A, Thompson C, Dayan CM. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomized controlled trial. Lancet 2011, 378(9786):129-139. 10.1016/S0140-6736(11)60442-X, 21705068.
33. Chief Medical Officers of England, Scotland, Wales, and Northern Ireland Start active, stay active: a report on physical activity from the four home countries' Chief Medical Officers 11 June 2011, UK: Department of Health, Physical activity, Health improvement and protection, Helath D, Chief Medical Officers of England, Scotland, Wales, and Northern Ireland.
34. American Diabetes Association Standards of medical care in diabetes - 2012. Diabetes Care 2012, 35:S11-S63. 3632172, 22187469, American Diabetes Association.
35. Greenhalgh T, Taylor R. Papers that go beyond numbers (qualitative research). BMJ 1997, 315:740-743. 10.1136/bmj.315.7110.740, 2127518, 9314762.
36. ACSM's guidelines for exercise testing and prescription 2010, 76-79. Lippincott: Williams and Wilkins, Eighth.
37. Swain DP, Abernathy KS, Smith CS, Lee SJ, Bunn SA. Target heart rates for the development of cardiorespiratory fitness. Med Sci Sport Exer 1994, 26(1):112-116.
38. National Institute for Clinical Excellence Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults [internet] 2012, [updated 2010 March]. Available from: http://www.nice.org.uk/CG15, National Institute for Clinical Excellence.
39. Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P. What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 2012, 55(3):542-551. 10.1007/s00125-011-2403-2, 22189486.